⌘K

Login Start Free

Home/Filings/4/0001193125-26-006264

4//SEC Filing

Dube Michael P 4

Accession 0001193125-26-006264

CIK 0001652130other

View on SEC.gov Company Profile

Filed

Jan 6, 7:00 PM ET

Accepted

Jan 7, 4:01 PM ET

Size

4.8 KB

Accession

0001193125-26-006264

Insider Transaction Report

Form 4

Period: 2026-01-05

Intellia Therapeutics, Inc.NTLA

VP, Chief Accounting Officer

Transactions

Sale
Common Stock
2026-01-05$9.21/sh−2,989$27,529→ 52,277 total

Footnotes (1)

[F1]Represents a mandatory "sell-to-cover" transaction for the purpose of satisfying the reporting person's tax withholding obligation upon the vesting of RSUs on January 1, 2026, and does not represent a volitional trade by the Reporting Person.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Intellia Therapeutics, Inc.

CIK 0001652130

Entity typeother

Related Parties

1

filerCIK 0002019493

Filing Metadata

Form type: 4
Filed: Jan 6, 7:00 PM ET
Accepted: Jan 7, 4:01 PM ET
Size: 4.8 KB

View on SEC.gov